title: Pegylated liposomal doxorubicin in the treatment of cutaneous T-cell lymphoma.
authors.forename: H M
authors.initials: HM
authors.lastname: Prince
authors.forename: J F
authors.initials: JF
authors.lastname: Seymour
authors.forename: G
authors.initials: G
authors.lastname: Ryan
authors.forename: C
authors.initials: C
authors.lastname: McCormack
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage*; D006801:Humans; D008081:Liposomes; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D008081:Liposomes; D004317:Doxorubicin